Synopsys launches $1 billion accelerated share repurchase program
Bitget2026/10/05 13:18Synopsys launched a USD 1 billion accelerated share repurchase agreement with JPMorgan Chase Bank to buy back its stock. Initial delivery set at about 1,735,000 shares. Final settlement due on or before Jan. 5, 2027. Ultimate share count tied to the average daily volume-weighted average price during the repurchase period, minus a discount. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Synopsys Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610050900PR_NEWS_USPR_____SF63372) on October 05, 2026, and is solely responsible for the information contained therein.
- Synopsys launched a USD 1 billion accelerated share repurchase agreement with JPMorgan Chase Bank to buy back its stock.
- Initial delivery set at about 1,735,000 shares.
- Final settlement due on or before Jan. 5, 2027.
- Ultimate share count tied to the average daily volume-weighted average price during the repurchase period, minus a discount.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. stocks move | Moderna (MRNA.US) rises 7% after being included in the Nasdaq 100 Index
According to information from Zhihui Finance APP, on Friday, Moderna (MRNA.US) surged as much as 10% during trading, reaching its highest share price since December 2022. As of press time, the gain narrowed to 7%, with the stock trading at $210.95. On the news front, on October 9, Moderna was officially included in the Nasdaq 100 index, replacing Warner Bros Discovery. After its inclusion, some broad-based institutions that previously did not allocate to biotech will now passively hold the stock, while active institutions will add the company to their watch lists, increasing attention on the individual stock.
FCC Chairman Carr expresses satisfaction with the progress of the Disney lawsuit
FCC Chairman Carr stated that he is "satisfied" with the progress of the lawsuit against Disney (DIS.US).
Crypto prices
More
